Loading IOVA...
Iovance Biotherapeutics Inc.IOVAAs of 31 July 2026
−53
PositiveNegative
Equilibrium
Asymmetry
Is Iovance Biotherapeutics Inc. a good buy right now?
Whether Iovance Biotherapeutics Inc. (IOVA) looks like a good buy comes down to three things: how it is valued, how the market feels about it, and how strong the underlying business is. Each is measured against Iovance Biotherapeutics Inc.'s own five-year history, so you see genuine dislocation rather than noise. Information, not advice.
Iovance Biotherapeutics Inc.IOVALast 5 years
V—E—F—A—
——
IOVA priceasymmetryquant.com